Locations:

Tag: steven nissen

June 1, 2016/Heart, Vascular and Thoracic/Research

C5Research: A Case Study in Bolstering Confidence in Clinical Trials

A veteran academic research organization finds its mission more critical than ever

April 3, 2016/Heart, Vascular and Thoracic/News & Insights

ACCELERATE Shows Third Time’s No Charm for CETP Inhibitors

Trial stopped early after evacetrapib fails to budge event rate

October 20, 2015/Heart, Vascular and Thoracic/Research

Plaque Paradox: Statins Increase Calcium in Atheromas Even as They Shrink Them

Not all coronary calcium is the same, analysis shows

August 27, 2015/Heart, Vascular and Thoracic/News & Insights

Heart Risk and Diet: What Do We Tell Patients Now? (Infographic)

A checklist of the latest evidence to share with patients

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

August 18, 2015/Heart, Vascular and Thoracic/News & Insights

Approval of First PCSK9 Inhibitor Marks New Era (Video)

How it fits into today’s cholesterol-lowering practice

June 12, 2015/Heart, Vascular and Thoracic/Research

PCSK9 Inhibitors Edge Closer to FDA Approval

A new option for patients who need more than statins

March 5, 2015/Heart, Vascular and Thoracic/News & Insights

The Best of AHA 2014

Leading cardiologist picks studies with most impact

January 29, 2015/Heart, Vascular and Thoracic/Research

Aspirin Fails to Prevent Cardiovascular Events in High-Risk Patients

Significant bleeding risk may outweigh any benefit

January 27, 2015/Heart, Vascular and Thoracic/Research

HDL Function Appears to Control Cholesterol-Lowering Ability

Amount of HDL may be less important than previously thought

January 20, 2015/Heart, Vascular and Thoracic/News & Insights

Ezetimibe Adds Incremental Benefit to Statin Therapy

Further lowering LDL reduces risk in post-ACS patients

BackPage 3 of 4Next